Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment Trial Title Principal Investigator
Cardiology CABANA - Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial  James Kappler,MD 
Cardiology Attain Success: A Prospective, Non-Randomized, Multi Center, Post-Market Global Clinical Trial  Jihn Han,MD 
Cardiology A Multi-Center, Randomized, Double-Blind, Parallel Group,Active-Controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients with Chronic Heart Failure and Reduced Ejection Fraction  Marlo Leonen, MD 
Cardiology SAVOR Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus  Mansoor A. Qureshi, MD 
Cardiology Double blind placebo controlled dose ranging study of the efficacy and safety of celivarone at 50, 100, or 300 mb once daily with amiodarone as calibrator for the prevention of ICD interventions or death.  James Kappler, MD 
Cardiology The Stabilization Of pLacques usIng Darapladib Thrombolysis In Myocardial Infarction 52 [SOLID-TIMI 52] Trial)  Herbert Aronow, MD 
Cardiology EDUCATE: Endeavor Drug eluting stenting: Understanding Care, Antiplatelet agents and Thrombotic Events  James Bengtson, MD 
Cardiology QuickFlex m MOdel 1258T Left Heart Pacing Lead Post Approval Study  Jihn Han, MD 
Cardiology PEGASUS - A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial to Assess the Prevention of Thrombotic Events with Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Pts w/History of MI  Mansoor Qureshi, MD 
Cardiology A Phase III, Randomized, Placebo-controlled, Double-Blind Trial of Flaxseed for the Treatment of Hot Flashes  Radmira Greenstein, MD 
Cardiology The LEVANT 2 Trial: The Moxy Drug Coated Balloon: Assessment of the Safety and Clinical Performance  Herbert Aronow, MD 
Cardiology Product Performance Platform: Post Market Approval Registries  Jihn Han, MD 
Cardiology A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-risk Subjects Presenting with Acute Vytorin Efficacy International Trial-(IMPROVE IT)  Qureshi MD, Mansoor A 
Cardiology CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions)  Aronow, M.D., Herbert  
Cardiology Carotid Stenting for High Surgical Risk Patients: Evaluating Outcomes through the Collection of Clinical Evidence (“CHOICE”)  Aronow, M.D., Herbert 
Cardiology The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-Expanding Astron and Astron Pulsar Stents  Herbert Aronow, MD 
Cardiology Stenting and Angioplasty with Protection in Patients at High-risk for Endarterectomy - SAPPHIRE  Aronow, M.D., Herbert  
Cardiology Study to Evaluate the Safety and Efficacy of SCH 530384 in Addition to Standard of Care in Subjects with a History of Atherosclerotic Disease: thrombin Receptor Antagonist i Secondary Prevention of Atherothrombotic Ischemic Events   Qureshi MD, Mansoor A 
Cardiology Coronary Stent Graft for Treatment of Free Perforations  O'Donnell, MD, Michael 
Cardiology GALAXY: Long-Term Evaluation of the Linox Family ICD Leads Registry  Jihn Han, MD 
Cardiology BLOCK HF: Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block  Shinn MD, Timothy 
Cardiology Medtronic Chronicle ICD  Leonen, Marlo 
Cardiology Multicenter Automatic Defibrillator Implantation Trial: Reduce Inappropriate Therapy (MADIT-RIT)  Timothy Shinn, MD 
Cardiology XIENCEV Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study (Protocol 06-374)  James Bengtson, MD 
Cardiology A Placebo-Controlled, Double-Blind, Randomized, Multi-Center Study to Assess the Effects of Multaq® 400 mg BID for 12 Weeks on Atrial Fibrillation Burden in Subjects with Permanent Pacemakers  James Kappler, MD 
Cardiology Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT)  Shinn MD, Timothy  
Cardiology SPORT ICD Registry  Loomis RN, Michelle 
Cardiology A Prospective, Single-Blind, Randomized, Multi-Center Study Comparing the CYPHER® ELITE to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems  Bengtson MD, James  
Cardiology OSPREY: Occlusive/Stenotic Peripheral artery Revascularization study): A Multi-center clinical trial of the Misago™ Self Expanding Stent System for Superficial Femoral Artery  Herbert D. Aronow, MD 
Cardiology Left Atrial Pressure Monitoring to Optimize Heart Failure (LAPTOP-HF)  Marlo Leonen, MD 
Cardiology EchoCRT Echocardiography Guided Cardiac Resynchronization Therapy Phase III  Steven Girard, MD 
Cardiology A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate the Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects with Nonvalvular Atrial Fibrillation (ARISTOTLE)  James Kappler, MD 
Cardiology PROMISE - Prospective Multi-center Imaging Study for Evaluation of Chest Pain  Tauqir Goraya, MD 
Cardiology The US Study for Evaluating Endovascular Treatments of Lesions in the Superficial Femoral Artery & Proximal Popliteal by Using the Protege Everflex Nitinol Stent System II (DURABILITY II)  Herbert Aronow, MD 
Cardiology CELESTIAL Post-Approval Registry  Jihn Han, MD 
Cardiology Randomized Evaluation of Long term anticoagulant therapy comparing the efficacy and safety of dabigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation  Goraya MD, Tauqir 
Cardiology Endovascular Valve Edge-to-Edge Repair Study II (EVEREST II).  O'DONNELL MD, MICHAEL 
Cardiology A Perspective, Randomized, Multi-Center, Double-Blind Trial to Assess Effectiveness & Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with the CYPHER Coronary Stent   Herbert Aronow, MD 
Cardiology Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST)  Aronow, M.D., Herbert 
Cardiology The ACUITY Trial: A randomized comparison of Angiomax (bivalirudin) versus heparin (unfractionated heparin or enoxaparin ) in patients undergoing early invasive management for acute coronary syndromes without ST-segment elevation  Qureshi MD, Mansoor A 
Cardiology Safety and Efficacy of SCH530348 in Addition to Standard of Care in Subjects With Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)   James Bengtson, MD 
Cardiology Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)- PROTECT  Aronow, M.D., Herbert  
Cardiology The ENDEAVOR - Small Vessell Stenting (SVS) Registry  James Bengtson, MD 
Cardiology Medtronic Post-MI Remodeling Prevention Therapy (Prompt)  Timothy S. Shinn, M.D. 
A Member of Trinity Health
© 2014 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456